Proto Labs, Inc. filings document the regulatory record for an NYSE-listed digital manufacturing company that produces custom parts for prototyping, testing, bridge production, short-run production, and end-use applications. Its SEC disclosures cover operating results, revenue by service activity, non-GAAP measures, cash-flow commentary, and business updates related to CNC machining, digital platforms, and manufacturing capacity.
PRLB filings also include Form 8-K material-event reports for earnings releases and executive leadership changes, amendments to previously furnished results information, and proxy materials covering board matters, executive compensation, equity awards, shareholder voting items, and governance. The company’s filings identify its common stock under the PRLB ticker on the New York Stock Exchange.
Proto Labs (PRLB) filed an initial Form 3 for a new executive. The reporting person serves as Chief Technology & AI Officer and indicated no securities are beneficially owned.
The filing was made by one reporting person and includes a Power of Attorney as an exhibit.
Proto Labs, Inc. reported a leadership change in its technology organization. On October 3, 2025, the company announced that Chief Technology Officer Oleg Ryaboy will depart and cease to be an employee effective November 2, 2025, and is no longer an executive officer as of that notice date.
Marc Kermisch has been appointed as the new Chief Technology & AI Officer, effective October 13, 2025, marking a transition that adds explicit responsibility for artificial intelligence. Upon departure, Mr. Ryaboy will receive severance benefits under the company’s existing Form of Executive Severance Agreement. The company also issued a press release detailing this leadership transition.
Disciplined Growth Investors, Inc. reports beneficial ownership of 2,722,011 shares of Proto Labs Inc. common stock, representing 11.4% of the outstanding class. The filer states it has sole voting power over 2,446,527 shares and sole dispositive power over all 2,722,011 shares, and that the securities were acquired and are held in the ordinary course of business rather than to influence control. The filing lists the issuers principal office in Maple Plain, Minnesota, and the reporting persons office in Minneapolis. The statement is signed by the firm's Chief Compliance Officer on 08/14/2025.
Proto Labs (PRLB) Form 4: President & CEO Suresh Krishna bought 1,725 common shares on 08/04/2025 in open-market transactions coded “P.” The weighted-average purchase price was $43.51 (range $43.47-$43.53), implying an aggregate outlay of roughly $75.5 thousand. Following the purchase, Krishna’s direct beneficial ownership rose to 18,021 shares, up about 11% from the prior holding. No sales, derivative transactions, or other insiders were reported in this filing.
The form contains no amendments, 10b5-1 notation, or additional footnotes beyond the pricing breakdown, and it does not reference any derivative securities. The filing therefore reflects a single, straightforward insider purchase that increases executive equity exposure.